Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.

Michaelis KA, Norgard MA, Zhu X, Levasseur PR, Sivagnanam S, Liudahl SM, Burfeind KG, Olson B, Pelz KR, Ramos DMA, Maurer HC, Olive KP, Coussens LM, Morgan TK, Marks DL.

Nat Commun. 2019 Nov 15;10(1):5257. doi: 10.1038/s41467-019-13151-z.

PMID:
31729370
2.

Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia.

Arshad H, Alfonso JCL, Franke R, Michaelis K, Araujo L, Habib A, Zboromyrska Y, Lücke E, Strungaru E, Akmatov MK, Hatzikirou H, Meyer-Hermann M, Petersmann A, Nauck M, Brönstrup M, Bilitewski U, Abel L, Sievers J, Vila J, Illig T, Schreiber J, Pessler F.

J Transl Med. 2019 Nov 11;17(1):365. doi: 10.1186/s12967-019-2112-z.

3.

The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.

Michaelis KA, Norgard MA, Zhu X, Levasseur PR, Sivagnanam S, Liudahl SM, Burfeind KG, Olson B, Pelz KR, Angeles Ramos DM, Maurer HC, Olive KP, Coussens LM, Morgan TK, Marks DL.

Nat Commun. 2019 Oct 15;10(1):4682. doi: 10.1038/s41467-019-12657-w. Erratum in: Nat Commun. 2019 Nov 15;10(1):5257.

4.

Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance.

Michaelis KA, Norgard MA, Levasseur PR, Olson B, Burfeind KG, Buenafe AC, Zhu X, Jeng S, McWeeney SK, Marks DL.

Brain Behav Immun. 2019 Nov;82:338-353. doi: 10.1016/j.bbi.2019.09.004. Epub 2019 Sep 6.

5.

Inhibition of histone acetylation and deacetylation enzymes affects longevity, development, and fecundity in the pea aphid (Acyrthosiphon pisum).

Kirfel P, Skaljac M, Grotmann J, Kessel T, Seip M, Michaelis K, Vilcinskas A.

Arch Insect Biochem Physiol. 2019 Sep 9:e21614. doi: 10.1002/arch.21614. [Epub ahead of print]

PMID:
31498475
6.

Temporal and spatial discounting are distinct in humans.

Robinson E, Michaelis K, Thompson JC, Wiener M.

Cognition. 2019 Sep;190:212-220. doi: 10.1016/j.cognition.2019.04.030. Epub 2019 May 20.

PMID:
31121404
7.

MyD88 signalling is critical in the development of pancreatic cancer cachexia.

Zhu X, Burfeind KG, Michaelis KA, Braun TP, Olson B, Pelz KR, Morgan TK, Marks DL.

J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):378-390. doi: 10.1002/jcsm.12377. Epub 2019 Jan 21.

8.

Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNA.

Schumann C, Nguyen DX, Norgard M, Bortnyak Y, Korzun T, Chan S, Lorenz AS, Moses AS, Albarqi HA, Wong L, Michaelis K, Zhu X, Alani AWG, Taratula OR, Krasnow S, Marks DL, Taratula O.

Theranostics. 2018 Oct 22;8(19):5276-5288. doi: 10.7150/thno.27847. eCollection 2018.

9.

Hepatitis A virus infections, immunisations and demographic determinants in children and adolescents, Germany.

Michaelis K, Poethko-Müller C, Kuhnert R, Stark K, Faber M.

Sci Rep. 2018 Nov 12;8(1):16696. doi: 10.1038/s41598-018-34927-1.

10.

Two concurrent outbreaks of hepatitis A highlight the risk of infection for non-immune travellers to Morocco, January to June 2018.

Gassowski M, Michaelis K, Wenzel JJ, Faber M, Figoni J, Mouna L, Friesema IH, Vennema H, Avellon A, Varela C, Sundqvist L, Lundberg Ederth J, Plunkett J, Balogun K, Ngui SL, Midgley SE, Gillesberg Lassen S, Müller L.

Euro Surveill. 2018 Jul;23(27). doi: 10.2807/1560-7917.ES.2018.23.27.1800329.

11.

TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia.

Burfeind KG, Zhu X, Levasseur PR, Michaelis KA, Norgard MA, Marks DL.

Brain Behav Immun. 2018 Oct;73:364-374. doi: 10.1016/j.bbi.2018.05.021. Epub 2018 May 28.

12.

Establishment and characterization of a novel murine model of pancreatic cancer cachexia.

Michaelis KA, Zhu X, Burfeind KG, Krasnow SM, Levasseur PR, Morgan TK, Marks DL.

J Cachexia Sarcopenia Muscle. 2017 Oct;8(5):824-838. doi: 10.1002/jcsm.12225. Epub 2017 Jul 20.

13.

Ongoing haemolytic uraemic syndrome (HUS) outbreak caused by sorbitol-fermenting (SF) Shiga toxin-producing Escherichia coli (STEC) O157, Germany, December 2016 to May 2017.

Vygen-Bonnet S, Rosner B, Wilking H, Fruth A, Prager R, Kossow A, Lang C, Simon S, Seidel J, Faber M, Schielke A, Michaelis K, Holzer A, Kamphausen R, Kalhöfer D, Thole S, Mellmann A, Flieger A, Stark K.

Euro Surveill. 2017 May 25;22(21). pii: 30541. doi: 10.2807/1560-7917.ES.2017.22.21.30541.

14.

Hepatitis A virus infections and outbreaks in asylum seekers arriving to Germany, September 2015 to March 2016.

Michaelis K, Wenzel JJ, Stark K, Faber M.

Emerg Microbes Infect. 2017 Apr 26;6(4):e26. doi: 10.1038/emi.2017.11.

15.

Ongoing outbreaks of hepatitis A among men who have sex with men (MSM), Berlin, November 2016 to January 2017 - linked to other German cities and European countries.

Werber D, Michaelis K, Hausner M, Sissolak D, Wenzel J, Bitzegeio J, Belting A, Sagebiel D, Faber M.

Euro Surveill. 2017 Feb 2;22(5). doi: 10.2807/1560-7917.ES.2017.22.5.30457.

16.

A distinct brain pathway links viral RNA exposure to sickness behavior.

Zhu X, Levasseur PR, Michaelis KA, Burfeind KG, Marks DL.

Sci Rep. 2016 Jul 20;6:29885. doi: 10.1038/srep29885.

17.

Functional correlates of likelihood and prior representations in a virtual distance task.

Wiener M, Michaelis K, Thompson JC.

Hum Brain Mapp. 2016 Sep;37(9):3172-87. doi: 10.1002/hbm.23232. Epub 2016 May 11.

PMID:
27167875
18.

The central role of hypothalamic inflammation in the acute illness response and cachexia.

Burfeind KG, Michaelis KA, Marks DL.

Semin Cell Dev Biol. 2016 Jun;54:42-52. doi: 10.1016/j.semcdb.2015.10.038. Epub 2015 Nov 3. Review.

19.

Passive listening to preferred motor tempo modulates corticospinal excitability.

Michaelis K, Wiener M, Thompson JC.

Front Hum Neurosci. 2014 Apr 24;8:252. doi: 10.3389/fnhum.2014.00252. eCollection 2014.

20.

Sustained hyperoxia-induced NF-κB activation improves survival and preserves lung development in neonatal mice.

McKenna S, Michaelis KA, Agboke F, Liu T, Han K, Yang G, Dennery PA, Wright CJ.

Am J Physiol Lung Cell Mol Physiol. 2014 Jun 15;306(12):L1078-89. doi: 10.1152/ajplung.00001.2014. Epub 2014 Apr 18.

21.

IκBβ-mediated NF-κB activation confers protection against hyperoxic lung injury.

Michaelis KA, Agboke F, Liu T, Han K, Muthu M, Galambos C, Yang G, Dennery PA, Wright CJ.

Am J Respir Cell Mol Biol. 2014 Feb;50(2):429-38. doi: 10.1165/rcmb.2013-0303OC.

22.

The NF-κB inhibitory proteins IκBα and IκBβ mediate disparate responses to inflammation in fetal pulmonary endothelial cells.

Tang JR, Michaelis KA, Nozik-Grayck E, Seedorf GJ, Hartman-Filson M, Abman SH, Wright CJ.

J Immunol. 2013 Mar 15;190(6):2913-23. doi: 10.4049/jimmunol.1202670. Epub 2013 Feb 15.

23.

Reprimo (RPRM) is a novel tumor suppressor in pituitary tumors and regulates survival, proliferation, and tumorigenicity.

Xu M, Knox AJ, Michaelis KA, Kiseljak-Vassiliades K, Kleinschmidt-DeMasters BK, Lillehei KO, Wierman ME.

Endocrinology. 2012 Jul;153(7):2963-73. doi: 10.1210/en.2011-2021. Epub 2012 May 4.

24.

Nuclear factor-κB (NF-κB) inhibitory protein IκBβ determines apoptotic cell death following exposure to oxidative stress.

Wright CJ, Agboke F, Muthu M, Michaelis KA, Mundy MA, La P, Yang G, Dennery PA.

J Biol Chem. 2012 Feb 24;287(9):6230-9. doi: 10.1074/jbc.M111.318246. Epub 2012 Jan 5.

25.

Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors.

Michaelis KA, Knox AJ, Xu M, Kiseljak-Vassiliades K, Edwards MG, Geraci M, Kleinschmidt-DeMasters BK, Lillehei KO, Wierman ME.

Endocrinology. 2011 Oct;152(10):3603-13. doi: 10.1210/en.2011-0109. Epub 2011 Aug 2.

26.

Giant pituitary adenomas: pathologic-radiographic correlations and lack of role for p53 and MIB-1 labeling.

Madsen H, Borges TM, Knox AJ, Michaelis KA, Xu M, Lillehei KO, Wierman ME, Kleinschmidt-DeMasters BK.

Am J Surg Pathol. 2011 Aug;35(8):1204-13. doi: 10.1097/PAS.0b013e31821e8c96.

PMID:
21753697
27.

Improvised transvenous cardiac pacing during Operation Enduring Freedom.

Handler TE, Michaelis KJ, Bruno TA, Martin DJ.

Pacing Clin Electrophysiol. 2012 Jul;35(7):e187-8. doi: 10.1111/j.1540-8159.2011.03136.x. Epub 2011 May 23.

PMID:
21605143
28.

PEGylation improves nanoparticle formation and transfection efficiency of messenger RNA.

Uzgün S, Nica G, Pfeifer C, Bosinco M, Michaelis K, Lutz JF, Schneider M, Rosenecker J, Rudolph C.

Pharm Res. 2011 Sep;28(9):2223-32. doi: 10.1007/s11095-011-0464-z. Epub 2011 May 19.

PMID:
21594715
29.

8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder.

Singh TP, Schön MP, Wallbrecht K, Michaelis K, Rinner B, Mayer G, Schmidbauer U, Strohmaier H, Wang XJ, Wolf P.

J Immunol. 2010 Jun 15;184(12):7257-67. doi: 10.4049/jimmunol.0903719. Epub 2010 May 19.

30.

Modulating T cell functions does not alleviate chronic inflammatory skin lesions in K5.TGF beta 1 transgenic mice.

Michaelis K, Wallbrecht K, Kerstan A, Beyersdorf N, Williams C, Kerkau T, Wang XJ, Hünig T, Schön MP.

Exp Dermatol. 2010 May;19(5):406-15. doi: 10.1111/j.1600-0625.2009.01031.x. Epub 2010 Jan 19.

PMID:
20100197
31.

Profiling of levoamphetamine and related substances in dexamphetamine sulfate by capillary electrophoresis.

Kokiashvili NG, Wongwan S, Landgraf C, Michaelis K, Hammitzsch-Wiedemann M, Scriba GK.

J Pharm Biomed Anal. 2009 Dec 5;50(5):1050-3. doi: 10.1016/j.jpba.2009.06.018. Epub 2009 Jun 16.

PMID:
19574012
32.

The cardiovascular patient's perceptions of complementary and alternative medicine.

Krasuski RA, Michaelis K, Eckart RE.

Clin Cardiol. 2006 Apr;29(4):161-4.

33.

Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain.

Michaelis K, Hoffmann MM, Dreis S, Herbert E, Alyautdin RN, Michaelis M, Kreuter J, Langer K.

J Pharmacol Exp Ther. 2006 Jun;317(3):1246-53. Epub 2006 Mar 22.

PMID:
16554356
34.

The transcriptional antiterminator RfaH represses biofilm formation in Escherichia coli.

Beloin C, Michaelis K, Lindner K, Landini P, Hacker J, Ghigo JM, Dobrindt U.

J Bacteriol. 2006 Feb;188(4):1316-31.

35.

Regulation of type 1 fimbriae synthesis and biofilm formation by the transcriptional regulator LrhA of Escherichia coli.

Blumer C, Kleefeld A, Lehnen D, Heintz M, Dobrindt U, Nagy G, Michaelis K, Emödy L, Polen T, Rachel R, Wendisch VF, Unden G.

Microbiology. 2005 Oct;151(Pt 10):3287-98.

PMID:
16207912
36.

Lack of interaction of milnacipran with the cytochrome p450 isoenzymes frequently involved in the metabolism of antidepressants.

Puozzo C, Lens S, Reh C, Michaelis K, Rosillon D, Deroubaix X, Deprez D.

Clin Pharmacokinet. 2005;44(9):977-88.

PMID:
16122284
37.

Scaffold attachment factor B1 functions in development, growth, and reproduction.

Ivanova M, Dobrzycka KM, Jiang S, Michaelis K, Meyer R, Kang K, Adkins B, Barski OA, Zubairy S, Divisova J, Lee AV, Oesterreich S.

Mol Cell Biol. 2005 Apr;25(8):2995-3006.

38.

Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells.

Wartlick H, Michaelis K, Balthasar S, Strebhardt K, Kreuter J, Langer K.

J Drug Target. 2004;12(7):461-71.

PMID:
15621671
39.

Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.

Balthasar S, Michaelis K, Dinauer N, von Briesen H, Kreuter J, Langer K.

Biomaterials. 2005 May;26(15):2723-32.

PMID:
15585276
40.

SAFB2, a new scaffold attachment factor homolog and estrogen receptor corepressor.

Townson SM, Dobrzycka KM, Lee AV, Air M, Deng W, Kang K, Jiang S, Kioka N, Michaelis K, Oesterreich S.

J Biol Chem. 2003 May 30;278(22):20059-68. Epub 2003 Mar 26.

41.

Analysis of genome plasticity in pathogenic and commensal Escherichia coli isolates by use of DNA arrays.

Dobrindt U, Agerer F, Michaelis K, Janka A, Buchrieser C, Samuelson M, Svanborg C, Gottschalk G, Karch H, Hacker J.

J Bacteriol. 2003 Mar;185(6):1831-40.

42.

Selective cleavage of unpaired uridines with a tyrosine-cyclen conjugate.

Michaelis K, Kalesse M.

Chembiochem. 2001 Jan 8;2(1):79-83. No abstract available.

PMID:
11828431
43.

Type 1 pili of Citrobacter freundii mediate invasion into host cells.

Hess P, Daryab N, Michaelis K, Reisenauer A, Oelschlaeger TA.

Adv Exp Med Biol. 2000;485:225-35. No abstract available.

PMID:
11109110
44.

Selective Cleavage of the HIV-1 TAR-RNA with a Peptide-Cyclen Conjugate.

Michaelis K, Kalesse M.

Angew Chem Int Ed Engl. 1999 Aug;38(15):2243-2245.

PMID:
10425497
45.

In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women.

Kuhnz W, Heuner A, Hümpel M, Seifert W, Michaelis K.

Contraception. 1997 Dec;56(6):379-85.

PMID:
9494772
46.

Quantitative determination of pentaerythrityl tetranitrate and its metabolites in human plasma by gas chromatography/mass spectrometry.

Stalleicken D, Kuntze U, Schmid B, Hiebl R, Ring J, Michaelis K.

Arzneimittelforschung. 1997 Apr;47(4):347-52.

PMID:
9150853
47.

Bioequivalence evaluation of two preparations containing the highly variable compound selegiline (L-deprenyl).

Waitzinger J, Ludwig G, Pabst G, Michaelis K, Reh C.

Int J Clin Pharmacol Ther. 1996 Oct;34(10):427-32.

PMID:
8897080
48.

Lack of a pharmacokinetic interaction between moexipril and hydrochlorothiazide.

Hutt V, Michaelis K, Verbesselt R, De Schepper PJ, Salomon P, Bonn R, Cawello W, Angehrn JC.

Eur J Clin Pharmacol. 1996;51(3-4):339-44.

PMID:
9010710
49.

Pharmacokinetics and bioavailability of pentaerithrityl tetranitrate and two of its metabolites.

Weber W, Michaelis K, Luckow V, Kuntze U, Stalleicken D.

Arzneimittelforschung. 1995 Jul;45(7):781-4.

PMID:
8573222
50.

[The traveling patient with hypoxia].

Savoy J, Michaelis K.

Rev Med Suisse Romande. 1995 Mar;115(3):205-8. Review. French. No abstract available.

PMID:
7777757

Supplemental Content

Loading ...
Support Center